Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Clinical
NovaBay Pharmaceuticals to Hold Third Quarter 2020 Conference Call on November…
Clinical
OliX Pharmaceuticals Announces FDA Clearance of the IND to Evaluate the…
Commercial
BioSpace Movers & Shakers, Oct. 30
Commercial
Q32 Stays Busy with $60 Million Series B and First Dose…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Immuno-oncology
Iovance Biotherapeutics to Host Third Quarter 2020 Financial Results Conference Call…
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
Clearside Biomedical to Report Third Quarter 2020 Financial Results and Provide…
Commercial
Oyster Point Pharma to Report Third Quarter 2020 Financial Results on…
Immuno-oncology
Iovance Biotherapeutics to Host Third Quarter 2020 Financial Results Conference Call…
Clinical
Trevena, Inc. Announces DEA Scheduling of OLINVYK (oliceridine) injection – FirstWord…
Home
Therapy areas
Immuno-oncology
Immuno-oncology
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Immuno-oncology
Iovance Biotherapeutics to Host Third Quarter 2020 Financial Results Conference Call and Webcast on Thursday, November 5, 2020
Biospace News
-
November 5, 2020
Immuno-oncology
Fall Clinical Dermatology 2020: Lilly and Incyte Showcase Positive New Data for Baricitinib in Adult Patients with Alopecia Areata
Immuno-oncology
OSE Immunotherapeutics Presents OSE-230 as a Novel Agonist Monoclonal Antibody Therapy Triggering Resolution of Chronic Inflammation
Immuno-oncology
Sana Biotechnology Announces Acquisition of Oscine
Immuno-oncology
Bellicum Announces Interim BPX-601 Data and Corporate Restructuring Nasdaq:BLCM
Immuno-oncology
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Firstwordpharma News
-
October 25, 2020
0
Immuno-oncology
Cyclacel Pharmaceuticals Announces Appointment of Mark Kirschbaum, M.D., as Chief Medical...
Globenewswire News
-
October 23, 2020
0
Immuno-oncology
BioSpace Movers & Shakers, Oct. 23
Biospace News
-
October 23, 2020
0
Immuno-oncology
BerGenBio Virtual R&D Day – 06 November 2020
Biospace News
-
October 23, 2020
0
Immuno-oncology
First Patient Dosed in Monalizumab Phase 3 Clinical Trial Triggers $50M...
Biospace News
-
October 23, 2020
0
1
2
3
...
70
Page 1 of 70
- Advertisement -
MOST POPULAR
Alnylam and 23andMe Collaborate on +MyFamily Program to Increase Awareness of...
July 16, 2019
BIOCORP Signs Exclusive Deal With VITROBIO PHARMA to Produce the First...
November 15, 2019
MD Anderson on a Roll with Another Pharma Deal, This Time...
November 6, 2019
Sirnaomics to Present Data Demonstrating STP705 Augmentation of Immune Checkpoint Inhibitors...
February 25, 2019
Load more
HOT NEWS
Acquisitions
The Wait Is Over: After Multiple Delays, Roche Completes Acquisition of...
Commercial
InMed Pharmaceuticals Appoints Catherine Sazdanoff to Board of Directors
Deals
Sumitomo Dainippon Pharma and Exscientia Joint Development New Drug Candidate Created...
Clinical
Daiichi Sankyo Provides Update on FDA Review of Quizartinib for the...
